• 1
    Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50: 733.
  • 2
    Connell PP, Rotmensch J, Waggoner SE, Mundt AJ. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 1999; 94: 713720.
  • 3
    Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998; 17: 24132417.
  • 4
    Simpkins SB, Bocker T, Swisher EM, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet. 1999; 8: 661666.
  • 5
    Soares J, Pinto AE, Cunha CV, et al. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer. 1999; 85: 112118.
  • 6
    Tang X, Khuri FR, Lee JJ, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in Stage I non-small-cell lung cancer. J Natl Cancer Inst. 2000; 92: 15111516.
  • 7
    Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000; 343: 13501354.
  • 8
    Yan PS, Rodriguez FJ, Laux DE, Perry MR, Standiford SB, Huang TH. Hypermethylation of ribosomal DNA in human breast carcinoma. Br J Cancer. 2000; 82: 514517.
  • 9
    Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. 2000; 89: 17581764.
  • 10
    Brock GJ, Bird A. Mosaic methylation of the repeat unit of the human ribosomal RNA genes. Hum Mol Genet. 1997; 6: 451456.
  • 11
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 12
    Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163170.
  • 13
    International Federation of Gynecologists and Obstetricians. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 1989; 28: 189.
  • 14
    Roberts JA, Brunetto VL, Keys HM, et al. A Phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma. Abstract of the 29th annual meeting of the Society of Gynecologic Oncologists. 1998; 35: 70.
  • 15
    Maxwell GL, Risinger JI, Alvarez AA, Barrett JC, Berchuck A. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol. 2001; 97: 417422.
  • 16
    Fiumicino S, Ercoli A, Ferrandina G, et al. Microsatellite instability is an independent indicator of recurrence in sporadic Stage I–II endometrial adenocarcinoma. J Clin Oncol. 2001; 19: 10081014.
  • 17
    MacDonald ND, Salvesen HB, Ryan A, Iversen OE, Akslen LA, Jacobs IJ. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res. 2000; 60: 17501752.
  • 18
    Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40: 5565.
  • 19
    Naumann RW, Higgins RV, Hall JB. The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists. Gynecol Oncol. 1999; 75: 49.
  • 20
    MacLeod C, Fowler A, Duval P, et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys. 1998; 42: 10331039.
  • 21
    Corn BW, Lanciano RM, Greven KM, et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 1994; 12: 510515.
  • 22
    Lewandowski G, Torrisi J, Potkul RK, et al. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates. Gynecol Oncol. 1990; 36: 401404.
  • 23
    Schink JC, Lurain JR, Wallemark CB, Chmiel JS. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol. 1987; 70: 216219.
  • 24
    Hicks ML, Kim W, Abrams J, Johnson CC, Blount AC, Parham GP. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 1997; 89: 134140.
  • 25
    Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol. 1997; 65: 812.
  • 26
    Maxwell GL, Risinger JI, Hayes KA, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res. 2000; 6: 29993005.